Pharmacists in Weirton, West Virginia


45 Pharmacists found in Weirton
male pharmacist

Mark Robinson


Pharmacist
1360 Cove Rd, Weirton, WV 26062
304-723-2110     304-723-9729

female pharmacist

Mary L Davis, R.PH.


Pharmacist
265 Penco Rd, Weirton, WV 26062
304-723-2656     304-723-2657

female pharmacist

Dr. Megan Michele Diserio, PHARMD


Pharmacist
651 Colliers Way, Weirton, WV 26062
304-723-6331    



female pharmacist

Megan Lynn Boniti, PHARMD


Pharmacist
265 Penco Road, Weirton, WV 26062
304-723-2656    

female pharmacist

Molly Dobbins


Pharmacist
651 Colliers Way Ste 204, Weirton, WV 26062
304-723-6331    

female pharmacist

Monica L Pulice, R.PH.


Pharmacist
3136 West St, Weirton, WV 26062
304-748-4200    

male pharmacist

Dr. Nicholas Aaron Robinson, PHARMD


Pharmacist
400 Three Springs Dr, Weirton, WV 26062
304-723-3450    

female pharmacist

Dr. Nicole Danielle Smith, RPH, PHARMD, BCPS


Pharmacist
601 Colliers Way, Pharmacy, Weirton, WV 26062
304-797-6504     304-797-6162

male pharmacist

Mr. Patsy V Longhi, RPH


Pharmacist
204 Three Springs Drive, Suite A, Weirton, WV 26062
304-723-2528     304-723-2540

female pharmacist

Samantha Mcquaid


Pharmacist
1360 Cove Rd, Weirton, WV 26062
304-723-2110    

female pharmacist

Sue Bernabei, RPH


Pharmacist
651 Colliers Way, Suite 204, Weirton, WV 26062
304-723-6331     304-723-1131

male pharmacist

Theodore Ameredes, R.PH.


Pharmacist
265 Penco Rd, Weirton, WV 26062
304-723-2656     304-723-2657

male pharmacist

Mr. Vincent B Decaria, RPH


Pharmacist
3901 Brightway St, Weirton, WV 26062
304-797-9240    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.